Madhu P. Menon, MD, PhD, FCAP, FASCP

Associate Professor, University of Utah School of Medicine

Specialties

• Hematopathology and hematology (benign and malignant)
• Molecular hematopathology
• Lymphomas (Hodgkin and non-Hodgkin)
• Leukemias

Education

• Medical Degree—Baroda Medical College, Maharaja Sayajirao University
• Doctorate Degree—Molecular Medicine, Huck Institute of Life Sciences, Pennsylvania State University
• Residency—Anatomic and Clinical Pathology, University of Massachusetts Medical School
• Fellowship—Hematopathology, National Institutes of Health/National Cancer Institute
• Visiting Fellowship—Hematopathology, Johns Hopkins University Hospital
• Visiting Fellowship—Hematopathology, George Washington University Hospital
• Clinical Observership—Hematopathology, Massachusetts General Hospital
• Fellowship—Postdoctoral, Maine Medical Center Research Institute

Current/Past Roles

• Associate Editor, Laboratory Medicine, American Society for Clinical Pathology Journal
• Member, Hematopathology Checkpath committee, American Society for Clinical Pathology
• Program Chair, Society for Hematopathology program at ASCP
• Medical Director, Henry Ford Cancer Institute Laboratory, and Senior Staff Pathologist, Henry Ford Hospital
• Chair, Pathology Professional Evaluation Committee, Henry Ford Hospital
• Chair, Clinical Competency Committee, Henry Ford Hospital
• CLIA Laboratory Director, Henry Ford Hospital (Livonia, Canton, Pierson, and Woodhaven)
• Associate Program Director, Pathology Residency Program, Henry Ford Hospital

Certification/Affiliations

• American Board of Pathology, Hematopathology
• American Board of Pathology, Anatomic Pathology
• American Board of Pathology, Clinical Pathology
• LEAN Silver Certification, LEAN Training for Healthcare Leaders

Research Interests

• Diagnostic and prognostic markers in lymphomas and leukemias
• Molecular characterization of lymphomas and leukemias
• Biomarkers for early detection of progression and transformation of low-grade lymphomas

Awards

• Teacher of the Year, Henry Ford Pathology Residency Program, 2018–2019 
• Teacher of the Year, Henry Ford Pathology Residency Program, 2015–2016 
• Fellow, American Society for Clinical Pathology (FASCP), 2014
• Fellow, College of American Pathologists (FCAP), 2011
• Stowell-Orbison Award Nominee, United States and Canadian Academy of Pathology (USCAP), 2010
• Association of Indian Pathologists in North America (AIPNA) USCAP Poster Award, 2010
• College of American Pathologists (CAP) Advanced Hematopathology Training Award, 2009–2010 
• J. Huck Institute of Life Sciences Predoctoral Fellowship Award in Molecular Medicine: Integrative Biosciences Program, Pennsylvania State University, August 2001–August 2003

Recent Publications

• Kaur A, Rojek AE, Symes E, et al. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024;14(1):99.
• Germinotropic HHV8+ LPD, Hematopathology Checkpath module, 1^st quarter, 2024.
• Vijayanarayanan A, Menon MP. Cholesterol pericarditis. N Engl J Med. 2022;387(11):1021.
•  Vijayanarayanan A, Shaw BM, Gibbons K, et al. The need for rapid cytogenetics in the era of unique therapies for acute myeloid leukemia. Blood Adv. 2022;6(24):6210-6212.
• Ganapathi KA, Karner KH, Menon MP. Peripheral T-cell lymphomas of the T follicular helper type: clinical, pathological, and genetic attributes. Hemato. 2022;3(1):268-286.
• Anderson J, Putnam E, Liu W, et al. Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase. Int J Lab Hematol. 2022;44(1):67-68.
• Fatima S, D'sa H, Chaffins ML, et al. An elderly male with a chronic rash of the right foot. Indian J Dermatol. 2020;65(3):222-224.  
• Van Slambrouck C, Huh J, Suh C, et al. Diagnostic utility of STAT6^YE361 expression in classical Hodgkin lymphoma and related entities. Mod Pathol. 2020;33(5):834-845.
• Vaddepally RK, Hejab A, Dabak V, et al. A rare case of follicular lymphoma transformed to a high-grade B-cell lymphoma in orbit. Clin Case Rep. 2019;7(5):1053-1056.
• Kezlarian B, Alhyari M, Venkataraman G, et al. GATA3 immunohistochemical staining in Hodgkin lymphoma: diagnostic utility in differentiating classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and other mimicking entities. Appl Immunohistochem Mol Morphol. 2019;27(3):180-184.